Quality of life in immune thrombocytopenia following treatment

Objective To determine the impact of therapy on the reported health-related quality of life (HRQoL) in children with primary immune thrombocytopenia (ITP) using the Kids ITP tool (KIT). Design Secondary data analysis of the international and North American KIT validation studies. Results 217 childre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of disease in childhood 2013-11, Vol.98 (11), p.895-897
Hauptverfasser:	Grainger, John D, Young, Nancy L, Blanchette, Victor S, Klaassen, Robert J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Age Analysis Biological and medical sciences Care and treatment Child Child, Preschool Children & youth Demographic aspects Diagnosis Evaluation Families & family life Female General aspects General Paediatrics Glucocorticoids - adverse effects Glucocorticoids - therapeutic use Haematology Hematologic and hematopoietic diseases Humans Immunoglobulins, Intravenous - therapeutic use Individualized Transition Plans Isoantibodies - adverse effects Isoantibodies - therapeutic use ITP Male Medical sciences Miscellaneous Mortality Observation Outcome Measures Parents Patient care Patients Physicians Platelet diseases and coagulopathies Practice Prednisone - adverse effects Prednisone - therapeutic use Prevention and actions Psychometrics Public health. Hygiene Public health. Hygiene-occupational medicine Purpura, Thrombocytopenic, Idiopathic - drug therapy Purpura, Thrombocytopenic, Idiopathic - rehabilitation Quality of Life Rho(D) Immune Globulin Severity of Illness Index Statistical Significance Studies Thrombocytopenia Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!